Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa, Merck Patent GmbhfiledCriticalSanofi Sa
Publication of GT201300148ApublicationCriticalpatent/GT201300148A/en
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Abstract
EN LA PRESENTE INVENCIÓN SE PROPORCIONAN PROCEDIMIENTOS PARA TRATAR PACIENTES CON CÁNCER, EN DONDE LOS PROCEDIMIENTOS COMPRENDEN ADMINISTRAR AL PACIENTE UNA CANTIDAD EFICAZ DE UN INHIBIDOR DE MEK Y UNA CANTIDAD EFICAZ DE UN INHIBIDOR DE PI3K. TAMBIÉN SE DESCRIBEN COMPOSICIONES EN LAS QUE LOS INHIBIDORES DE MEK Y DE PI3K ESTÁN EN COMBINACIÓNIN THE PRESENT INVENTION PROCEDURES ARE PROVIDED TO TREAT PATIENTS WITH CANCER, WHERE THE PROCEDURES INCLUDE TO ADMINISTER THE PATIENT AN EFFECTIVE AMOUNT OF A MEK INHIBITOR AND AN EFFICIENT AMOUNT OF A PI3K INHIBITOR. COMPOSITIONS ARE ALSO DESCRIBED IN WHICH THE MEK AND PI3K INHIBITORS ARE IN COMBINATION
GT201300148A2010-12-092013-06-07
COMPOSITIONS AND METHODS TO TREAT CANCER USING A P13K INHIBITOR AND A MEK INHIBITOR
GT201300148A
(en)